Europe's medicines regulator said Thursday there appeared to be no higher risk of blood clots in those vaccinated against Covid-19, after Denmark, Norway and Iceland suspended use of the AstraZeneca jab. "The information available so far indicates that the number of thromboembolic events in vaccinated people is no higher than that seen in the general population," the European Medicines Agency told AFP by email when asked about the suspension. jhe/dk/bp